Sam Altman’s Fusion Power Bet Just Got Hotter Than The Sun

Fusion power moves closer to commercialization. Storing data for 10,000 years. Why AI won’t necessarily take your job. All that and more in this week’s edition of The Prototype.

The 50 Hottest Fintech Startups In 2026

Even as AI took center stage in 2025, many fintechs–especially those with a business-to-business focus–thrived.

The Future Of Personal Finance: Fintech 50 2026

These startups focus on improving the everyday elements of personal finance, including banking, access to credit and budgeting.

The Future Of Investing: Fintech 50 2026

From a fast-growing prediction markets startup to firms that help people invest in retirement accounts, these three investing companies made the Fintech 50 for 2026.

The Future Of Insurance: Fintech 50 2026

From one startup that tries to simplify the confusion of selecting health insurance to another that uses aerial imagery instead of in-person inspectors, five insurtech businesses made our Fintech 50.

Masimo Founder Joe Kiani On The Healthtech Company’s $10 Billion Acquisition

In this week’s edition of InnovationRx, we look at Jennifer Doudna’s $1 billion plan to bring Crispr gene editing to the real world, using “boring” AI in clinics and more.

Betting App Novig Raises $75 Million As It Looks To Join Prediction Market Wave

Multiple pivots since the sports gambling firm launched in 2021 have paid off with a $500 million valuation. Now it is chasing federal approval—and industry heavyweights Kalshi and Polymarket.

Ex-Top Tesla Engineer Raises $140 Million To Rewire The Electric Grid

Heron Power, backed by Andreessen Horowitz and Breakthrough Energy, is scaling up production of solid-state transformers that more efficiently move power to the grid.

Legal AI Startup Legora Eyes $400 Million Raise At $5 Billion-Plus Valuation

As investors double down on the promise of automating legal work, the company is in talks to raise $400 million following two rounds in late 2025.

Gene Editing Has Struggled To Go Commercial. This Nobel Laureate Has A $1 Billion Plan To Fix That.

Crispr’s ability to cut genetic code like scissors has just started to turn into medicines. Now, gene editing pioneer Jennifer Doudna wants to build an entire ecosystem to bring these treatments mainstream.